Further studies need to determine whether the disease activity of GPA and EGPA in patients with anti-MYL6 antibody is lower than in anti-MYL6 antibody-negative GPA/EGPA patients. The gene discussed is MYL6; the disease is granulomatosis with polyangiitis.